Deforolimus (Ridaforolimus)
Catalog No. A10295
Deforolimus (Ridaforolimus)是mTOR蛋白的研究目标靶向小分子抑制剂。阻断mTOR通过干扰细胞生长,分裂,代谢和血管生成,在癌细胞中产生饥饿样的效应。
Catalog Num | A10295 |
---|---|
M. Wt | 990.2 |
Formula | C53H84NO14P |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 572924-54-0 |
Synonyms | AP23573, MK-8669, MK8669 |
SMILES | C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OP(=O)(C)C)C)/C)O)OC)C)C)/C)OC |
Deforolimus (Ridaforolimus)是mTOR蛋白的研究目标靶向小分子抑制剂。阻断mTOR通过干扰细胞生长,分裂,代谢和血管生成,在癌细胞中产生饥饿样的效应。
Targets
mTOR (HT-1080 cells) | ||||
0.2 nM |
In vitro (25°C) | DMSO | 196 mg/mL (197.93 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 5% DMSO+40% PEG 300+5% Tween 80+50% H2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 10.1 mL | 50.49 mL | 100.99 mL |
0.5 mM | 2.02 mL | 10.1 mL | 20.2 mL |
1 mM | 1.01 mL | 5.05 mL | 10.1 mL |
5 mM | 0.2 mL | 1.01 mL | 2.02 mL |
*The above data is based on the productmolecular weight 990.2. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.